000			01829 a2200517 4500
005			20250517110411.0
264		0	_c20171002
008			201710s 0 0 eng d
022			_a1878-8769
024	7		_a10.1016/j.wneu.2016.07.063 _2doi
040			_aNLM _beng _cNLM
100	1		_aRasouli, Jonathan J
245	0	0	_aThe Adjunctive Use of Vancomycin Powder Appears Safe and May Reduce the Incidence of Surgical-Site Infections After Deep Brain Stimulation Surgery. _h[electronic resource]
260			_bWorld neurosurgery _cNov 2016
300			_a9-13 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Topical
650	0	4	_aAged
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAntibiotic Prophylaxis _xmethods
650	0	4	_aBurkholderia Infections _xdrug therapy
650	0	4	_aBurkholderia cepacia
650	0	4	_aCefuroxime _xtherapeutic use
650	0	4	_aDeep Brain Stimulation
650	0	4	_aDevice Removal
650	0	4	_aDoxycycline _xtherapeutic use
650	0	4	_aDystonia _xtherapy
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aIntraoperative Care
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeurosurgical Procedures
650	0	4	_aParkinson Disease _xtherapy
650	0	4	_aPowders
650	0	4	_aProsthesis Implantation
650	0	4	_aProsthesis-Related Infections _xepidemiology
650	0	4	_aRetrospective Studies
650	0	4	_aStaphylococcal Infections _xdrug therapy
650	0	4	_aStaphylococcus aureus
650	0	4	_aSurgical Wound Infection _xepidemiology
650	0	4	_aVancomycin _xtherapeutic use
700	1		_aKopell, Brian Harris
773	0		_tWorld neurosurgery _gvol. 95 _gp. 9-13
856	4	0	_uhttps://doi.org/10.1016/j.wneu.2016.07.063 _zAvailable from publisher's website
999			_c26281042 _d26281042